Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Puretech Health Plc (PRTC.LN)

Puretech Health Plc (PRTC.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 560,146
  • Shares Outstanding, K 269,950
  • Annual Sales, $ 2,090 K
  • Annual Income, $ -50,354 K
  • 60-Month Beta N/A
  • Price/Sales 425.86
  • Price/Cash Flow N/A
  • Price/Book 1.36
Trade PRTC.LN with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.17
  • Most Recent Earnings N/A on N/A
  • Latest Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
204.500 +0.98%
on 04/19/24
230.500 -10.41%
on 03/26/24
-16.500 (-7.40%)
since 03/19/24
3-Month
179.200 +15.23%
on 02/14/24
230.500 -10.41%
on 03/26/24
+16.900 (+8.91%)
since 01/19/24
52-Week
139.000 +48.56%
on 12/11/23
242.925 -14.99%
on 06/09/23
-2.000 (-0.96%)
since 04/19/23
Free Barchart Webinars! Live educational sessions using site features to explore today's markets.

Most Recent Stories

More News
PureTech Founded Entity Akili Announces Adults with ADHD See Significant Improvements in Attention, ADHD Symptoms, and Quality of Life in Clinical Trial of Akili’s EndeavorRx® Video Game-Based Therapeutic Business Wire - Thu May 4, 2023

PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (“PureTech” or the “Company”), a clinical-stage biotherapeutics company noted today that its Founded Entity, Akili, Inc. (Nasdaq: AKLI) (“Akili”),...

PRTC : 26.15 (-2.91%)
PRTC.LN : 206.500 (-0.48%)
AKLI : 0.2380 (+2.50%)
PureTech Announces Annual Results for Year Ended December 31, 2022 Business Wire - Fri Apr 28, 2023

PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (“PureTech” or the “Company”) today announces its results for the year ended December 31, 2022, as well as its cash balance as of the first quarter...

PRTC : 26.15 (-2.91%)
PRTC.LN : 206.500 (-0.48%)
BIIB : 194.38 (+2.03%)
KRTX : 329.83 (+0.03%)
VOR : 1.7100 (+1.79%)
AKLI : 0.2380 (+2.50%)
PureTech Founded Entity Vedanta Biosciences Announces $106.5 Million Financing to Advance Pipeline of Defined Bacterial Consortia Therapies Business Wire - Tue Apr 25, 2023

PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (“PureTech” or the “Company”), a clinical-stage biotherapeutics company, noted today that its Founded Entity, Vedanta Biosciences , a clinical-stage...

PRTC : 26.15 (-2.91%)
PRTC.LN : 206.500 (-0.48%)
PureTech Founded Entity Vedanta Biosciences Publishes Phase 2 Results in the Journal of the American Medical Association and Presents at ECCMID Business Wire - Mon Apr 17, 2023

PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (“PureTech” or the “Company”), a clinical-stage biotherapeutics company, noted today that its Founded Entity, Vedanta Biosciences, a clinical-stage...

PRTC : 26.15 (-2.91%)
PRTC.LN : 206.500 (-0.48%)
PureTech Health: Notice of Results Business Wire - Thu Apr 13, 2023

PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company") plans to publish its annual report and financial results on Friday, April 28, 2023, at 2:00 AM EDT/ 7:00 AM BST. The report...

PRTC : 26.15 (-2.91%)
PRTC.LN : 206.500 (-0.48%)
PureTech Health and Royalty Pharma Enter into KarXT Royalty Agreement for up to $500 Million Business Wire - Thu Mar 23, 2023

PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company"), a clinical-stage biotherapeutics company dedicated to changing the treatment paradigm for devastating diseases, and Royalty...

PRTC : 26.15 (-2.91%)
PRTC.LN : 206.500 (-0.48%)
RPRX : 28.16 (+0.97%)
PureTech to Present at the Barclays Global Healthcare Conference Business Wire - Wed Mar 1, 2023

PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company"), a clinical-stage biotherapeutics company dedicated to changing the treatment paradigm for devastating diseases, today announced...

PRTC : 26.15 (-2.91%)
PRTC.LN : 206.500 (-0.48%)
PureTech Founded Entity Sonde Health and Massachusetts General Hospital Selected for National Institute on Aging Study to Examine Use of Voice in Remote Detection and Monitoring of Mild Cognitive Impairment Including Frontotemporal Disorders (FTD) Business Wire - Mon Feb 27, 2023

PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (“PureTech” or the “Company”), a clinical-stage biotherapeutics company, noted today that its Founded Entity, Sonde Health , a health technology...

PRTC : 26.15 (-2.91%)
PRTC.LN : 206.500 (-0.48%)
PureTech to Advance LYT-300 (Oral Allopregnanolone) for the Potential Treatment of Anxiety Disorders and Postpartum Depression Business Wire - Tue Feb 14, 2023

PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company"), a clinical-stage biotherapeutics company dedicated to changing the treatment paradigm for devastating diseases, today announced...

PRTC : 26.15 (-2.91%)
PRTC.LN : 206.500 (-0.48%)
PureTech to Present at the SVB Securities Global Biopharma Conference Business Wire - Wed Feb 1, 2023

PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company"), a clinical-stage biotherapeutics company dedicated to changing the treatment paradigm for devastating diseases, today announced...

PRTC : 26.15 (-2.91%)
PRTC.LN : 206.500 (-0.48%)
More news for this symbol

Barchart Technical Opinion

buy

The Barchart Technical Opinion rating is a 64% Buy with a Weakening short term outlook on maintaining the current direction.

See More Share

PRTC.LN Quotes API

Key Turning Points

3rd Resistance Point 214.167
2nd Resistance Point 211.833
1st Resistance Point 209.167
Last Price 206.500
1st Support Level 204.167
2nd Support Level 201.833
3rd Support Level 199.167

See More

52-Week High 242.925
Last Price 206.500
Fibonacci 61.8% 203.226
Fibonacci 50% 190.962
Fibonacci 38.2% 178.699
52-Week Low 139.000

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot